Tetratherix Limited (ASX:TTX)
Australia · Delayed Price · Currency is AUD 5.08
+0.16 (3.25%)
Apr 20, 2026, 12:51 PM AEST
Tetratherix Market Cap
Tetratherix has a market cap or net worth of 257.89 million as of April 20, 2026.
Market Cap
257.89M
Enterprise Value
247.53M
Revenue
2.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.08
Market Cap Chart
Since June 30, 2025, Tetratherix's market cap has increased from 152.00M to 257.89M, an increase of 69.66%. That is a compound annual growth rate of 92.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 257.89M | 56.21% |
| Dec 30, 2025 | 165.09M | 8.61% |
| Jun 30, 2025 | 152.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Racura Oncology | 570.87M |
| Clinuvel Pharmaceuticals | 461.42M |
| Starpharma Holdings | 292.70M |
| Orthocell | 280.80M |
| Dimerix | 237.16M |
| Recce Pharmaceuticals | 164.83M |
| Actinogen Medical | 143.66M |
| Alterity Therapeutics | 108.75M |